Disparity in market prices for hepatitis C virus direct-acting drugs
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patents covering various aspects of direct-acting antivirals prevent the entry of competitors, allowing originator companies to select the price for the market.48”
From The legal determinants of health: harnessing the power of law for global health and sustainable development (2019) · cites this paper as [48]
Citations
Cites
Church, J. A. (2001) · Journal of Government Information · doi:10.1016/s1352-0237(01)00307-0 · Cited by 9,153
EASL Recommendations on Treatment of Hepatitis C 2015
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.025 · Cited by 1,156
Hill, A., Khoo, S., Fortunak, J., Simmons, B., & Ford, N. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu012 · Cited by 216
Cited by
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Cooke, G. S., Andrieux-Meyer, I., Applegate, T. L., Atun, R., Burry, J. R., Cheinquer, H., Dusheiko, G., Feld, J. J., Gore, C., Griswold, M. G., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30270-x · Cited by 535
Self-citationGostin, L. O., Monahan, J. T., Kaldor, J., DeBartolo, M., Friedman, E. A., Gottschalk, K., Kim, S. C., Alwan, A., Binagwaho, A., Burci, G. L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30233-8 · Cited by 338
“46, [50] [51] [52] [53] [54] [55] [56] [57] [58] Where patents exist and have been unsuccessfully challenged, another option available to groups and countries is voluntary licence agreements.”
BackgroundIyengar, S., Tay-Teo, K., Vogler, S., Beyer, P., Wiktor, S., de Joncheere, K., & Hill, S. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002032 · Cited by 255
Metadata
- Authors
- Andrieux-Meyer, I., Cohn, J., de Araújo, E. S. A., & Hamid, S. S.
- Affiliations
- Médecins Sans Frontières (CH)
- Aga Khan University (PK)
- Venue
- The Lancet Global Health
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 3
- Issue
- 11
- Pages
- e676-e677
- ISSN
- 2214-109X (ISSN-L)
- OpenAlex
- W1745658487
- Cited by
- 83
- References
- 3
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 7 · 2020: 6 · 2019: 13 · 2018: 14 · 2017: 18 · 2016: 14
- FWCI
- 37.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Global Health (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Medecins Sans Frontieres Field Research (Medecins Sans Frontieres) (submittedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- hepatitis C, direct-acting antivirals, drug prices, price disparity, access to medicines, drug pricing
- MeSH terms
- Antiviral Agents, Commerce, Hepatitis C, Humans, Drug Costs, Healthcare Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disparity in market prices for hepatitis C virus direct-acting drugs. https://app.cochat.ai/papers/10.1016/s2214-109x(15)00156-4
- The paper
- Andrieux-Meyer, I., Cohn, J., de Araújo, E. S. A., & Hamid, S. S. (2015). Disparity in market prices for hepatitis C virus direct-acting drugs. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(15)00156-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.